AVITA Medical, Inc.
AVITA Medical, Inc.
Your view on AVH.AX
Overview
What the company does, where it operates, and who runs it.
About AVITA Medical, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Cary Guy Vance
- Headquarters
- 28159 Avenue Stanford, Valencia, CA, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Cary Guy Vance
- Headquarters
- 28159 Avenue Stanford, Valencia, CA, US
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs.
Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for AVITA Medical, Inc.. Starting points for AVITA Medical, Inc.: EPS -AUD 1.17, beta 2.00 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for AVITA Medical, Inc.. AVITA Medical, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for AVITA Medical, Inc.. Trailing twelve-month EPS for AVITA Medical, Inc. stands at -AUD 1.17. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Analyst Ratings
- Strong Buy0
- Buy5
- Hold0
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | −$0.03 | −$0.04 | −$0.18 | −$0.07 |
| Low estimate | −$0.03 | −$0.04 | −$0.26 | −$0.11 |
| High estimate | −$0.03 | −$0.04 | −$0.05 | −$0.01 |
| No. of analysts | 1 | 1 | 3 | 3 |
| Year-ago EPS | −$0.11 | −$0.101 | −$0.361 | — |
| Growth | +72.3% | — | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $26.24M | $25.35M | $94.15M | $116.24M |
| Low estimate | $25.02M | $24.65M | $92.21M | $107.43M |
| High estimate | $26.95M | $26.96M | $95.25M | $126.17M |
| No. of analysts | 5 | 4 | 7 | 7 |
| Year-ago revenue | $17.91M | $19.08M | $74.11M | — |
| Growth | +46.5% | +32.9% | +27.1% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for AVITA Medical, Inc.. AVITA Medical, Inc. has reported as a listed company since 1993. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| AHC.AXAustco Healthcare Limited | Healthcare | Medical - Instruments & Supplies | — | ||
| EMV.AXEMVision Medical Devices Ltd | Healthcare | Medical - Devices | — | ||
| IPD.AXImpediMed Limited | Healthcare | Medical - Devices | — | ||
| LDX.AXLumos Diagnostics Holdings Limited | Healthcare | Medical - Specialties | — | ||
| NYR.AXNyrada Inc. | Healthcare | Biotechnology | — | ||
| ONE.AXOneview Healthcare PLC | Healthcare | Medical - Healthcare Information Services | — | ||
| PAR.AXParadigm Biopharmaceuticals Limited | Healthcare | Biotechnology | — | ||
| PEB.AXPacific Edge Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CBLLCeriBell, Inc. | Healthcare | NASDAQ | $995.3M | ||
| CERSCerus Corporation | Healthcare | NASDAQ | $391.8M | ||
| CGHCCapital Group Holdings, Inc. | Healthcare | OTC | $9,220 | ||
| CHEOFCochlear Limited | Healthcare | OTC | $8.9B | ||
| CHEOYCochlear Limited | Healthcare | OTC | $9.2B | ||
| CHYPFHealth Logic Interactive Inc. | Healthcare | OTC | $165,839 | ||
| CLLKFBICO Group AB (publ) | Healthcare | OTC | $123.3M | ||
| CLPTClearPoint Neuro, Inc. | Healthcare | NASDAQ | $247.1M | ||
| CLVSFCellaVision AB (publ) | Healthcare | OTC | $378.0M | ||
| CMP.AXCompumedics Limited | Healthcare | ASX | — | ||
| CNMDCONMED Corporation | Healthcare | NYSE | $1.4B | ||
| CNVIFConavi Medical Corp. | Healthcare | OTC | $20.7M | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for AVITA Medical, Inc.. Coverage tracks AVITA Medical, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of AVITA Medical, Inc.